Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Zen Rating
Financials
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
ANNX
ANNEXON INC
$602.95M-93.10%-72.90%-111.57%-120.40%0.424.43N/AN/AN/A
PHIO
PHIO PHARMACEUTICALS CORP
$15.82M-86.40%-75.80%-80.83%960.20%0.176.90N/AN/AN/A
CBIO
CRESCENT BIOPHARMA INC
$129.62M-84.60%-71.60%-46.53%693.40%0.196.63N/AN/AN/A
CMND
CLEARMIND MEDICINE INC
$1.81M-208.10%-70.70%-317.50%172.70%4.101.22N/AN/AN/A
ORKA
ORUKA THERAPEUTICS INC
$1.58B-25.80%-24.80%-20.81%-31.60%0.0516.94N/AN/AN/A
RYTM
RHYTHM PHARMACEUTICALS INC
$6.84B-445.30%-47.70%-42.34%-84.70%1.424.7589.40%-113.40%-97.79%
REPL
REPLIMUNE GROUP INC
$599.48M-102.70%-72.20%-108.40%-88.80%0.585.60N/AN/AN/A
EVH
EVOLENT HEALTH INC
$303.55M-19.70%-7.20%-5.62%-13.50%1.911.3318.40%-8.80%-5.54%
BBNX
BETA BIONICS INC
$615.02M-46.80%-27.10%-25.55%-32.90%0.1210.6454.50%-87.90%-87.89%
TYRA
TYRA BIOSCIENCES INC
$1.55B-35.80%-33.60%-39.05%-47.60%0.0817.71N/AN/AN/A
ENTX
ENTERA BIO LTD
$65.12M-71.90%-63.40%-67.99%2,206.40%0.1410.830.00%-8,694.40%-8,683.06%
ENGN
ENGENE HOLDINGS INC
$662.48M-55.50%-46.00%-60.32%-54.00%0.326.30N/AN/AN/A
LFMD
LIFEMD INC
$137.19MN/A-10.80%-22.51%11.70%47.640.7387.00%-3.10%-0.83%
STEX
STREAMEX CORP
$100.43MN/A-65.00%-826.64%68.50%-19.740.12100.00%-306,861.50%-312,469.23%
DNLI
DENALI THERAPEUTICS INC
$2.83B-46.30%-41.00%-51.65%-47.40%0.149.79N/AN/AN/A
GNPX
GENPREX INC
$4.09M-891.70%-389.10%-1,658.99%-18,136.00%3.640.67N/AN/AN/A
VSTM
VERASTEM INC
$391.31MN/A-159.10%-204.07%-526.30%-12.392.5882.00%-1,802.10%-1,786.77%
ELDN
ELEDON PHARMACEUTICALS INC
$126.46M-94.90%-49.30%-65.03%-56.80%1.106.74N/AN/AN/A
XENE
XENON PHARMACEUTICALS INC
$3.22B-46.20%-43.40%-54.38%-55.80%0.0912.53100.00%-4,084.50%-4,129.39%
SNDA
SONIDA SENIOR LIVING INC
$655.07M-96.10%-6.20%-1.06%-0.60%25.810.7021.50%-13.90%-2.13%
ELAB
PMGC HOLDINGS INC
$238.12k-82.90%-63.50%-70.06%-523.90%0.761.7982.20%458.40%454.25%
LAB
STANDARD BIOTOOLS INC
$430.71M-29.30%-22.40%-29.33%-42.40%0.354.3847.90%-99.60%-98.29%
VTVT
VTV THERAPEUTICS INC
$145.39M-100.50%-47.80%-26.27%463.90%0.419.79100.00%-138,058.80%-138,029.41%
BMEA
BIOMEA FUSION INC
$94.04M-310.10%-145.40%-241.56%-1,835.00%2.533.18N/AN/AN/A
SRRK
SCHOLAR ROCK HOLDING CORP
$4.74B-122.00%-86.50%-100.33%-144.60%0.686.31N/AN/AN/A
ACLX
ARCELLX INC
$4.06B-51.10%-33.10%-46.45%-49.00%0.493.99100.00%-607.00%-695.50%
ARMP
ARMATA PHARMACEUTICALS INC
$296.09MN/A-54.50%63.18%-29.50%-1.940.12100.00%-3,797.70%-2,580.16%
IOVA
IOVANCE BIOTHERAPEUTICS INC
$1.04B-55.20%-43.10%-51.12%-96.30%0.293.4124.00%-158.80%-159.06%
QNRX
QUOIN PHARMACEUTICALS LTD
$13.16M-334.40%-125.20%-2,088.80%-453.90%-6.291.04N/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$1.73M-476.10%-253.90%-674.65%-20,966.60%1.541.66N/AN/AN/A
MGNX
MACROGENICS INC
$107.54M-98.30%-30.30%-31.21%-50.60%3.045.2275.40%-59.50%-55.34%
BTAI
BIOXCEL THERAPEUTICS INC
$34.55MN/A-185.00%-738.28%-61.10%-1.501.18-28.20%-9,070.60%-6,860.51%
IRON
DISC MEDICINE INC
$2.48B-31.60%-29.00%-29.38%-36.40%0.1023.45N/AN/AN/A
EYPT
EYEPOINT INC
$1.23B-76.10%-61.70%-92.76%-87.80%0.267.1894.10%-486.00%-485.49%
SRPT
SAREPTA THERAPEUTICS INC
$1.87B-20.30%-7.40%-9.81%-7.10%1.652.9576.30%-11.20%-10.45%
MAIA
MAIA BIOTECHNOLOGY INC
$72.95M-715.10%-199.20%-1,249.70%434.20%281.751.18N/AN/AN/A
NRIX
NURIX THERAPEUTICS INC
$1.61B-57.50%-43.80%-43.83%-59.10%0.287.02100.00%-314.90%-314.00%
NNOX
NANO-X IMAGING LTD
$150.42M-32.50%-29.00%-35.30%-75.50%0.124.14-98.00%-452.80%-469.77%
CYTK
CYTOKINETICS INC
$8.15BN/A-56.50%-54.98%-36.10%-3.766.88100.00%-862.20%-816.07%
NMTC
NEUROONE MEDICAL TECHNOLOGIES CORP
$34.31M-119.90%-78.90%-93.30%-308.90%0.346.4154.90%-78.30%-78.34%
IMUX
IMMUNIC INC
$110.30M-716.20%-252.10%-969.85%507.30%2.881.31N/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$167.49M-42.40%-40.30%-48.36%-70.10%0.0813.06N/AN/AN/A
CLNN
CLENE INC
$43.61MN/A-125.60%-200.24%-105.20%-2.811.5382.20%-14,250.50%-13,104.67%
ACET
ADICET BIO INC
$67.43M-77.90%-64.30%-94.62%-84.00%0.295.62N/AN/AN/A
AVIR
ATEA PHARMACEUTICALS INC
$359.38M-38.40%-35.90%-45.29%-48.10%0.0916.66N/AN/AN/A
RADX
RADIOPHARM THERANOSTICS LTD
$33.98M-99.40%-45.70%-50.41%-149.70%0.972.671.10%-997.40%-992.74%
VIR
VIR BIOTECHNOLOGY INC
$1.04B-50.80%-40.60%-52.89%-55.50%0.287.2595.90%-2,963.50%-2,961.95%
DCGO
DOCGO INC
$77.86M-17.20%-12.50%-25.25%-36.70%0.342.5931.20%-14.00%-19.22%
NKTR
NEKTAR THERAPEUTICS
$1.50B-356.80%-45.20%-40.25%-37.00%2.544.2487.30%-192.90%-151.11%
KOD
KODIAK SCIENCES INC
$1.20B-246.20%-78.40%-123.74%-76.50%8.201.79N/AN/AN/A
DNTH
DIANTHUS THERAPEUTICS INC
$2.11B-33.00%-31.10%-22.82%-34.90%0.0617.35100.00%-4,104.80%-4,104.78%
IKT
INHIBIKASE THERAPEUTICS INC
$127.05M-57.20%-52.80%-65.37%-217.00%0.0911.73N/AN/AN/A
DTIL
PRECISION BIOSCIENCES INC
$52.89M-213.80%-72.20%-104.61%-207.20%4.623.45100.00%-11,977.40%-11,767.34%
VANI
VIVANI MEDICAL INC
$91.92M-293.60%-79.50%-142.87%-80.80%18.130.61N/AN/AN/A
INO
INOVIO PHARMACEUTICALS INC
$87.32M-307.60%-127.90%24,665.13%-846.50%-9.990.79100.00%-59,281.70%-59,281.69%
TRAW
TRAWS PHARMA INC
$15.66M-2,912.00%518.00%2,048.95%-1,528.40%1.741.22100.00%3,280.00%3,280.04%
BNTC
BENITEC BIOPHARMA INC
$355.74M-38.90%-37.70%-23.66%4,739.40%0.0267.69N/AN/AN/A
GANX
GAIN THERAPEUTICS INC
$65.34M-341.30%-174.10%-266.08%1,085.50%0.862.52N/AN/AN/A
PMVP
PMV PHARMACEUTICALS INC
$56.40M-55.30%-51.00%-69.86%-78.60%0.1110.77N/AN/AN/A
CRSP
CRISPR THERAPEUTICS AG
$5.10B-31.50%-26.70%-27.31%-29.00%0.1813.32100.00%-16,569.80%-16,466.24%
VERA
VERA THERAPEUTICS INC
$2.74B-50.90%-42.70%-51.39%-43.50%0.3012.21N/AN/AN/A
SLDB
SOLID BIOSCIENCES INC
$428.51M-73.60%-60.00%-70.12%-112.70%0.266.74N/AN/AN/A
IFRX
INFLARX NV
$57.52M-68.50%-53.20%-86.90%-104.20%0.443.33-8,223.10%-63,818.90%-63,757.59%
ACHV
ACHIEVE LIFE SCIENCES INC
$225.71M-196.70%-118.30%-121.91%-306.00%0.555.14N/AN/AN/A
AARD
AARDVARK THERAPEUTICS INC
$271.08M-54.90%-37.90%-39.82%-58.70%0.0912.04N/AN/AN/A
CABA
CABALETTA BIO INC
$284.95M-107.10%-82.90%-108.54%-298.40%0.363.60N/AN/AN/A
CING
CINGULATE INC
$39.33M-394.50%-172.00%-475.88%-694.30%2.031.26N/AN/AN/A
CRDF
CARDIFF ONCOLOGY INC
$105.08M-77.20%-62.80%-102.75%-117.30%0.314.20100.00%-10,069.10%-10,064.27%
PCVX
VAXCYTE INC
$6.98B-21.10%-19.70%-22.12%-22.30%0.108.83N/AN/AN/A
MBOT
MICROBOT MEDICAL INC
$142.38M-37.10%-34.40%-16.58%-41.60%0.0527.53N/AN/AN/A
SMMT
SUMMIT THERAPEUTICS INC
$11.67B-311.20%-262.40%-463.89%-997.70%0.363.80N/AN/AN/A
PRME
PRIME MEDICINE INC
$597.49M-163.50%-61.20%-56.38%-72.20%1.386.61100.00%-3,301.60%-3,301.64%
OSUR
ORASURE TECHNOLOGIES INC
$197.27M-15.60%-13.30%-15.12%-44.50%0.177.0340.40%-47.90%-46.05%
RCKT
ROCKET PHARMACEUTICALS INC
$358.22M-62.40%-53.90%-70.95%-83.00%0.177.30N/AN/AN/A
SNGX
SOLIGENIX INC
$11.20M-267.10%-135.70%-149.12%441.10%0.493.18N/AN/AN/A
RCEL
AVITA MEDICAL INC
$132.02MN/A-78.40%693.27%-122.80%-4.390.5782.10%-67.80%-60.85%
AVTX
AVALO THERAPEUTICS INC
$273.28M-88.40%-73.90%-86.18%-288.20%0.3714.2854.70%-52,019.80%-52,575.52%
GRI
GRI BIO INC
$3.34M-381.70%-206.40%-198.51%624.90%0.443.25N/AN/AN/A
ELUT
ELUTIA INC
$49.11MN/A-76.40%197.10%-150.20%-1.670.4546.00%-125.60%-111.50%
MGTX
MEIRAGTX HOLDINGS PLC
$610.12M-1,065.50%-76.50%-427.19%-93.50%-5.670.2241.00%-615.30%-569.48%
BCTX
BRIACELL THERAPEUTICS CORP
$7.48M-277.90%-190.40%-299.07%-911.50%0.403.42N/AN/AN/A
AVBP
ARRIVENT BIOPHARMA INC
$940.39M-59.70%-55.70%-49.64%-90.90%0.0714.90N/AN/AN/A
LITS
LITE STRATEGY INC
$40.00M-68.90%-67.50%-48.50%-91.70%0.0110.04N/AN/AN/A
MYO
MYOMO INC
$30.94M-61.10%-30.80%-46.25%-56.30%1.332.4966.60%-28.90%-27.63%
TECX
TECTONIC THERAPEUTIC INC
$394.73M-27.10%-25.90%-24.75%9,383.70%0.0429.15N/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$90.95M-218.50%-154.20%-360.16%733.30%0.353.89N/AN/AN/A
PHGE
BIOMX INC
$9.01M-68.40%-35.00%-51.75%-43.60%1.501.70N/AN/AN/A
DFTX
DEFINIUM THERAPEUTICS INC
$1.66B-86.20%-62.30%-95.18%-120.30%0.813.30N/AN/AN/A
ABSI
ABSCI CORP
$399.99M-60.20%-50.90%-52.98%-103.30%0.175.89100.00%-4,071.20%-4,051.97%
BHVN
BIOHAVEN LTD
$1.22B-389.90%-153.40%-263.08%-206.40%-24.842.86N/AN/AN/A
CRBP
CORBUS PHARMACEUTICALS HOLDINGS INC
$132.00M-57.10%-50.90%-73.02%-67.30%0.196.31N/AN/AN/A
BCAX
BICARA THERAPEUTICS INC
$771.33M-27.20%-26.00%-30.02%-205.00%0.0514.14N/AN/AN/A
CDXS
CODEXIS INC
$109.29M-121.40%-47.40%-53.78%-37.00%2.224.1279.30%-120.80%-107.17%
CVRX
CVRX INC
$124.72M-99.30%-45.80%-51.92%-71.80%1.677.6385.30%-94.10%-83.84%
PMN
PROMIS NEUROSCIENCES INC
$34.81M-336.90%-184.40%-316.68%1,845.00%1.341.76N/AN/AN/A
ONCY
ONCOLYTICS BIOTECH INC
$101.25M-755.20%-188.30%-478.42%2,290.60%129.931.84N/AN/AN/A
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS INC
$852.68M-293.90%-59.90%-34.20%-117.30%0.0913.33N/AN/AN/A
IMA
IMAGENEBIO INC
$73.13M-36.90%-33.00%-30.17%-58.90%0.1513.24N/AN/AN/A
ETHZ
ETHZILLA CORP
$75.11M-199.50%-89.30%-23.60%-96.60%1.2710.07100.00%-5,671.90%-5,476.00%
CCCC
C4 THERAPEUTICS INC
$177.35M-64.40%-38.70%-51.82%-44.80%0.725.76100.00%-395.50%-395.08%

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
610+1.46%+0.32%-0.48%-29.81%203.20x5.16x-23.77%-9.51%-6.53%+67.37%Strong Buy
56-0.40%-4.39%-12.07%+6.08%16.70x3.97x-4.44%+6.36%+11.82%+22.58%Buy
20+0.36%+2.68%+8.12%+28.89%43.99x7.33x+100.80%+12.44%+21.08%+4.47%Buy
75+1.04%-0.27%+0.71%-27.50%-166.20x1.75x+9.97%+2.28%+5.20%+42.63%Buy
10-0.35%+4.19%-12.63%-24.67%19.38x1.91x+11.67%+3.66%+8.52%+20.65%Buy
54+0.76%-3.56%-18.69%-91.47%27.39x3.20x+8.66%+4.39%+6.53%+66.23%Buy
50-0.09%+5.82%+12.69%-30.49%16.89x5.91x-68.69%+7.69%+15.92%+10.21%Buy
139+1.82%-1.81%-5.06%-84.07%21.83x3.65x+11.89%+7.22%+9.67%+41.83%Strong Buy
10+0.90%+0.77%+10.03%+52.80%32.39x277.72x-98.61%+3.54%+23.66%+2.69%Buy
57+0.57%-0.94%-3.87%-14.92%171.28x3.06x+9.60%+8.37%+10.83%+23.32%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)


Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 51.92% over the past year, overperforming other healthcare stocks by 105 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -1.74% from Pediatrix Medical Group's current stock price of $21.71.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)


Bioventus (NASDAQ:BVS) is the #2 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 10 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -19.35% over the past year, overperforming other healthcare stocks by 33 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 55.13% from Bioventus's current stock price of $8.38.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #3 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 139% over the past year, overperforming other healthcare stocks by 192 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 35.98% from Ironwood Pharmaceuticals's current stock price of $4.78.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 29.06%, which is 27 percentage points higher than the healthcare sector average of 2.26%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.1%, which is 7 percentage points higher than the healthcare sector average of 2.26%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)


Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.81%, which is 6 percentage points higher than the healthcare sector average of 2.26%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.81% in the last day, and down -0.2% over the last week. Polaryx Therapeutics was the among the top gainers in the healthcare sector, gaining 64.32% yesterday.

Polaryx shares are trading higher after the company announced it selected a contract research organization for SOTERIA to evaluate PLX-200, across four different LSDs.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 68 points higher than the healthcare sector average of 18. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.88% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 53.58% in the past year. It has overperformed other stocks in the healthcare sector by 106 percentage points.

3. Organon & Co (NYSE:OGN)


Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -52.97% in the past year. It has performed in line with other stocks in the healthcare sector.

Are healthcare stocks a good buy now?

57.82% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.3% over the next year.

6.59% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.93% of healthcare stocks are rated B (Buy), 46.95% are rated C (Hold), 25.03% are rated D (Sell), and 8.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 59.51x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.